Melanocortin receptor agonists

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C514S253050, C514S254090, C514S218000, C544S121000, C544S363000, C544S373000, C540S575000

Reexamination Certificate

active

10466250

ABSTRACT:
The present invention relates to melanocortin receptor agonist of the formula I useful in the treatment of obesity, diabetes, and male and/or female sexual dysfunction

REFERENCES:
patent: 6294534 (2001-09-01), Nargund et al.
patent: WO 94 13696 (1994-06-01), None
patent: WO 99 55679 (1999-11-01), None
patent: WO 99 64002 (1999-12-01), None
patent: WO 00 74679 (2000-12-01), None
patent: WO 01 70337 (2001-09-01), None
patent: WO 01 70708 (2001-09-01), None
patent: WO 02 15909 (2002-02-01), None
patent: WO 02 059107 (2002-08-01), None
patent: WO 02 059108 (2002-08-01), None
patent: WO 02 059117 (2002-08-01), None
patent: WO 02 070511 (2002-09-01), None
Sebhat et al. Annual Reports in Medicinal Chemistry, vol. 38, p. 31-40 (2003).
Campfield et al. Science, vol. 280, p. 1383-1387 (1998).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Melanocortin receptor agonists does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Melanocortin receptor agonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Melanocortin receptor agonists will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3758504

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.